Compound 235
Identifiers
- Canonical SMILES:
CCOc1cc(ccc1C1=N[C@H]([C@@H](N1C(=O)N1CCC(CC1)NCC(=O)N(C)CCC#N)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(F)(F)F
- IUPAC name:
2-[[1-[4,5-bis(4-chlorophenyl)-2-[2-ethoxy-4-(trifluoromethyl)phenyl]-4,5-dihydroimidazole-1-carbonyl]piperidin-4-yl]amino]-N-(2-cyanoethyl)-N-methylacetamide
- InChi:
InChI=1S/C36H37Cl2F3N6O3/c1-3-50-30-21-25(36(39,40)41)9-14-29(30)34-44-32(23-5-10-26(37)11-6-23)33(24-7-12-27(38)13-8-24)47(34)35(49)46-19-15-28(16-20-46)43-22-31(48)45(2)18-4-17-42/h5-14,21,28,32-33,43H,3-4,15-16,18-20,22H2,1-2H3/t32-,33-/m0/s1
- InChiKey:
IQCPDPHGEWITPU-LQJZCPKCSA-N
External links
168315335 |
9379955 |
External search
Bibliography (1)
Publication | Name |
---|---|
Gregory Jay Haley, Norman Kong, Emily Aijun Liu, Klaus B. Simonsen, Binh Thanh Vu, Stephen Evan Webber, F. Hoffmann-La Roche Ag. . Cis-2,4,5-triaryl-imidazolines None. | 176 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 7.68 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 728.23 g/mol | |||
HBA | 9 | |||
HBD | 1 | |||
HBA + HBD | 10 | |||
AlogP | 5.60 | |||
TPSA | 101.27 | |||
RB | 11 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2005003097 | 176 | MDM2 Q00987 |
|
Biochemical assay | Time-Resolved FRET | pIC50 (half maximal inhibitory concentration, -log10) | 7.68 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.7963 | Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone | DB04144 | |
0.7911 | RO-5045337 | DB14793 | |
0.7105 | Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone | DB02872 | |
0.3893 | PCO-371 | DB14946 | |
0.3839 | Idanpramine | DB13276 | |
0.3831 | Sorbinil | DB02712 | |
0.3777 | (6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one | DB07874 | |
0.3770 | Irbesartan | DB01029 | |
0.3718 | Metralindole | DB09306 | |
0.3690 | Atecegatran metoxil | DB12507 | |
0.3686 | A-98881 | DB02804 | |
0.3674 | 5-[4-(2-Hydroxyethyl)-1-piperidinyl]-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione | DB03622 | |
0.3674 | Lopinavir | DB01601 | |
0.3643 | Fidarestat | DB02021 | |
0.3643 | (S,R)-fidarestat | DB02101 |